1. Antibody Drug Conjugates in Lung Cancer: State of the Current Therapeutic Landscape and Future Developments
   Joshua E. Reuss et al, 2021, Clinical Lung Cancer CrossRef
2. Curcumin and Its Analogs in Non-Small Cell Lung Cancer Treatment: Challenges and Expectations
   Chunyin Tang et al, 2022, Biomolecules CrossRef
3. The Potential of Curcumin: A Multitargeting Agent in Cancer Cell Chemosensitization
   Devivasha Bordoloi et al, 2018, Role of Nutraceuticals in Chemoresistance to Cancer CrossRef
4. Cell softening in malignant progression of human lung cancer cells by activation of receptor tyrosine kinase AXL
   Keisuke Iida et al, 2017, Scientific Reports CrossRef
5. Psoralidin protects against cerebral hypoxia/reoxygenation injury: Role of GAS6/Axl signaling
   Wangrui Lei et al, 2022, Phytotherapy Research CrossRef
6. Zerumbone-incorporated liquid crystalline nanoparticles inhibit proliferation and migration of non-small-cell lung cancer in vitro
   Bikash Manandhar et al, 2024, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
7. Antioxidants in Cancer Prevention
   Asad Ur Rahman et al, 2025, Antioxidants CrossRef
8. Berberine-loaded liquid crystalline nanoparticles inhibit non-small cell lung cancer proliferation and migration in vitro
   Keshav R. Paudel et al, 2022, Environmental Science and Pollution Research CrossRef
9. Targeting MERTK and AXL in EGFR Mutant Non-Small Cell Lung Cancer
   Dan Yan et al, 2021, Cancers CrossRef
10. Integrated Proteomics-Based Physical and Functional Mapping of AXL Kinase Signaling Pathways and Inhibitors Define Its Role in Cell Migration
    Anurima Majumder et al, 2022, Molecular Cancer Research CrossRef
11. Curcuminoid Nanovesicles as Advanced Therapeutics
    Hanna S. Abbo et al, 2023, ChemBioEng Reviews CrossRef
12. Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies
    Alessandro Allegra et al, 2017, Cancer Investigation CrossRef
13. Exploring the Gamut of Receptor Tyrosine Kinases for Their Promise in the Management of Non-Alcoholic Fatty Liver Disease
    Sayali Bhave et al, 2021, Biomedicines CrossRef
14. Nanoscale Formulations: Incorporating Curcumin into Combination Strategies for the Treatment of Lung Cancer
    Quhui Wu et al, 2021, Drug Design, Development and Therapy CrossRef
15. Recent Advances in Elucidating Paclitaxel Resistance Mechanisms in Non-small Cell Lung Cancer and Strategies to Overcome Drug Resistance
    Hongmei Cui et al, 2020, Current Medicinal Chemistry CrossRef
16. MicroRNA-509-3p inhibits cellular migration, invasion, and proliferation, and sensitizes osteosarcoma to cisplatin
    Sagar L. Patil et al, 2019, Scientific Reports CrossRef
17. Id-1 promotes osteosarcoma cell growth and inhibits cell apoptosis via PI3K/AKT signaling pathway
    Liang Hao et al, 2016, Biochemical and Biophysical Research Communications CrossRef
18. Processing and Physicochemical Properties of Magnetite Nanoparticles Coated with Curcuma longa L. Extract
    Margarita L. Alvarado-Noguez et al, 2023, Materials CrossRef
19. Versatile role of curcumin and its derivatives in lung cancer therapy
    Milad Ashrafizadeh et al, 2020, Journal of Cellular Physiology CrossRef
20. GTP-binding protein Di-RAS3 diminishes the migration and invasion of non-small cell lung cancer by inhibiting the RAS/extracellular-regulated kinase pathway
    Peng Kuang et al, 2022, Bioengineered CrossRef
21. Reconnoitering the Therapeutic Role of Curcumin in Disease Prevention and Treatment: Lessons Learnt and Future Directions
    Bala Mohan Sivani et al, 2022, Metabolites CrossRef
22. Ethyl pyruvate attenuates cerebral hypoxia/reoxygenation injury in neuroblastoma cells: Role of GAS6/Axl signaling
    Ying Chen et al, 2023, Heliyon CrossRef
23. Curcumin Nanoemulsion: Evaluation of Stability and Anti-Cancer Activity In Vitro
    Thanh Binh Nguyen et al, 2020, Journal of Nano Research CrossRef
24. Recent advances in codelivery of curcumin and siRNA as anticancer therapeutics
    Mehdi Sanati et al, 2023, European Polymer Journal CrossRef
25. Mistletoe ( Viscum album ) extract targets Axl to suppress cell proliferation and overcome cisplatin- and erlotinib-resistance in non-small cell lung cancer cells
    Soyoung Kim et al, 2017, Phytomedicine CrossRef
26. Antibody–drug conjugates for lung cancer in the era of personalized oncology
    Biagio Ricciuti et al, 2021, Seminars in Cancer Biology CrossRef
27. Discovery of novel and potent dual-targeting AXL/HDAC2 inhibitors for colorectal cancer treatment via structure-based pharmacophore modelling, virtual screening, and molecular docking, molecular dynamics simulation studies, and biological evaluation
    Xiao Qiao et al, 2024, Journal of Enzyme Inhibition and Medicinal Chemistry CrossRef
28. Giving AXL the axe: targeting AXL in human malignancy
    Carl M Gay et al, 2017, British Journal of Cancer CrossRef
29. Therapeutic potentials of curcumin in the treatment of non‐small‐cell lung carcinoma
    Mahsa Salehi et al, 2020, Phytotherapy Research CrossRef
30. AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications
    Chenjing Zhu et al, 2019, Molecular Cancer CrossRef
31. Properties and Biological Effects of Curcumin in Food Product Development
    Wing-Fu Lai et al, 2024, Food Reviews International CrossRef
32. Curcumin in Cancer and Inflammation: An In-Depth Exploration of Molecular Interactions, Therapeutic Potentials, and the Role in Disease Management
    Dong-Oh Moon, 2024, International Journal of Molecular Sciences CrossRef
33. Curcumin in cancer therapy: A novel adjunct for combination chemotherapy with paclitaxel and alleviation of its adverse effects
    Milad Ashrafizadeh et al, 2020, Life Sciences CrossRef